US HB3526 | 2011-2012 | 112th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 43-5)
Status: Introduced on November 30 2011 - 25% progression, died in committee
Action: 2011-12-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on November 30 2011 - 25% progression, died in committee
Action: 2011-12-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Heart Disease Education, Analysis, Research, and Treatment for Women Act or the HEART for Women Act - Directs the Comptroller General to report on whether the presentation of clinical study safety and effectiveness data by sex, age, and racial subgroups complies with Food and Drug Administration (FDA) requirements. Requires the Secretary of Health and Human Services (HHS) to submit a response to such report, including a corrective action plan as needed. Requires the Director of the Office of Women's Health of FDA to report on the compliance of clinical studies of women's health with such FDA requirements, including requirements regarding: (1) the adequacy of representation of females, racial and ethnic minorities, and adults of all ages in approved clinical studies; and (2) the extent to which a summary of product safety and effectiveness data disaggregated by sex, age, and racial subgroup is available to the public. Requires the Director of the Office of Minority Health of FDA to submit a report that includes such information with respect to clinical studies of minority health. Amends the Public Health Service Act to require the Secretary to report on the quality of, and access to, care for women with heart disease, stroke, and other cardiovascular diseases and to include recommendations for eliminating disparities in, and improving the treatment of, heart disease, stroke, and other cardiovascular diseases in women. Reauthorizes a program to award grants for preventive heath services and referrals for medical treatment for women through entities that are screening women for breast or cervical cancer. Requires the Secretary to study the impact of the Patient Protection and Affordable Care Act on such services and make recommendations for improvement in the provision of preventive health services, referrals, and followup services to women eligible for such services.
Title
Heart Disease Education, Analysis, Research, and Treatment for Women Act
Sponsors
History
Date | Chamber | Action |
---|---|---|
2011-12-02 | House | Referred to the Subcommittee on Health. |
2011-11-30 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
SB438 (Related) 2011-03-02 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Cardiovascular and respiratory health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Health care quality
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Licensing and registrations
Medical education
Medical research
Minority health
Prescription drugs
Women's health
Congressional oversight
Drug safety, medical device, and laboratory regulation
Government information and archives
Government studies and investigations
Health
Health care quality
Health information and medical records
Health programs administration and funding
Health promotion and preventive care
Licensing and registrations
Medical education
Medical research
Minority health
Prescription drugs
Women's health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/112th-congress/house-bill/3526/all-info |
Text | https://www.congress.gov/112/bills/hr3526/BILLS-112hr3526ih.pdf |